Marta Parera

456 total citations
9 papers, 322 citations indexed

About

Marta Parera is a scholar working on Oncology, Surgery and Reproductive Medicine. According to data from OpenAlex, Marta Parera has authored 9 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Surgery and 3 papers in Reproductive Medicine. Recurrent topics in Marta Parera's work include Ovarian cancer diagnosis and treatment (3 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Marta Parera is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Marta Parera collaborates with scholars based in Spain, Palestinian Territory and Germany. Marta Parera's co-authors include Aleix Prat, Sergio Peralta, J.M. del Campo, Antonio Gil‐Moreno, S. Cedrés, José Pérez, Pere Huguet, Jordi Andreu, José M. Martínez-Palones and Ángel García and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Marta Parera

9 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Parera Spain 8 154 111 77 71 67 9 322
Núria Baixeras Spain 11 111 0.7× 28 0.3× 34 0.4× 78 1.1× 111 1.7× 24 326
Kuniko Iihara Japan 9 77 0.5× 71 0.6× 19 0.2× 37 0.5× 31 0.5× 29 230
H. M. Peters Netherlands 8 105 0.7× 85 0.8× 45 0.6× 36 0.5× 124 1.9× 14 357
Maria Grazia Centurioni Italy 10 70 0.5× 86 0.8× 79 1.0× 21 0.3× 73 1.1× 23 308
Mouna Stayoussef Tunisia 13 77 0.5× 80 0.7× 26 0.3× 12 0.2× 64 1.0× 34 395
Vivian M. Spaans Netherlands 11 125 0.8× 73 0.7× 31 0.4× 49 0.7× 87 1.3× 13 350
Deirdre Lum United States 8 75 0.5× 57 0.5× 102 1.3× 17 0.2× 41 0.6× 23 575
Dorthe Ørnskov Denmark 13 121 0.8× 98 0.9× 22 0.3× 24 0.3× 122 1.8× 23 367
Lina Ghabreau Syria 13 275 1.8× 109 1.0× 20 0.3× 21 0.3× 150 2.2× 28 510
Valeria Visconti Italy 12 135 0.9× 93 0.8× 46 0.6× 13 0.2× 77 1.1× 22 352

Countries citing papers authored by Marta Parera

Since Specialization
Citations

This map shows the geographic impact of Marta Parera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Parera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Parera more than expected).

Fields of papers citing papers by Marta Parera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Parera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Parera. The network helps show where Marta Parera may publish in the future.

Co-authorship network of co-authors of Marta Parera

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Parera. A scholar is included among the top collaborators of Marta Parera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Parera. Marta Parera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Fidalgo, Berta, Elisa Rubio-García, Marta Parera, et al.. (2021). Improved diagnosis of gastrointestinal infections using a semi-automated multiplex real-time PCR for detection of enteropathogens. Journal of Medical Microbiology. 70(9). 10 indexed citations
2.
Ambrosioni, Juan, Omar Sued, David Nicolás, et al.. (2015). Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012). PLoS ONE. 10(6). e0125837–e0125837. 21 indexed citations
3.
Whitcher, Brandon, Volker Schmid, David J. Collins, et al.. (2011). A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck. Magnetic Resonance Materials in Physics Biology and Medicine. 24(2). 85–96. 8 indexed citations
4.
Campo, J.M. del, Aleix Prat, Antonio Gil‐Moreno, José Pérez, & Marta Parera. (2008). Update on novel therapeutic agents for cervical cancer. Gynecologic Oncology. 110(3). S72–S76. 55 indexed citations
5.
Prat, Aleix, Marta Parera, Bárbara Adamo, et al.. (2008). Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels. Annals of Oncology. 20(2). 294–297. 27 indexed citations
6.
Gil‐Moreno, Antonio, Berta Díaz‐Feijoó, Assumpció Pérez‐Benavente, et al.. (2008). Usefulness of extraperitoneal laparoscopic paraaortic lymphadenectomy for lymph node recurrence in gynecologic malignancy. Acta Obstetricia Et Gynecologica Scandinavica. 87(7). 723–730. 6 indexed citations
7.
Felip, Enriqueta, Federico Rojo, Martin Reck, et al.. (2008). A Phase II Pharmacodynamic Study of Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy. Clinical Cancer Research. 14(12). 3867–3874. 68 indexed citations
8.
Prat, Aleix, Marta Parera, Sergio Peralta, et al.. (2007). Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab‐based therapy. Head & Neck. 30(5). 680–683. 77 indexed citations
9.
Prat, Aleix, Marta Parera, Sergio Peralta, et al.. (2007). Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer. Annals of Oncology. 19(2). 327–331. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026